Expertise in
4
conditions

Aldo Hermosillo-Ferreira

Unidad De Investigación Médica En Enfermedades Nefrológicas CMN Siglo XXI, 
Unidad Del Seguro Social En Santa Fe, DIF, MX 
Expertise in
4
conditions
Unidad De Investigación Médica En Enfermedades Nefrológicas CMN Siglo XXI, 
Unidad Del Seguro Social En Santa Fe, DIF, MX 

Overview

Aldo Hermosillo-Ferreira practices practicing medicine in Unidad Del Seguro Social En Santa Fe, Mexico.

Mr. Hermosillo-Ferreira is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Obesity, Hypothyroidism, Virilizing Ovarian Tumor, and Parathyroidectomy.

He is actively involved in clinical research, co-authoring 89 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Unidad De Investigación Médica En Enfermedades Nefrológicas CMN Siglo XXI, Unidad Del Seguro Social En Santa Fe, DIF 06600, Mexico
Other Locations
Mexico City, DIF, Mexico
Cuauhtemoc, DIF 06720, Mexico
Seguro Social, MEX 06720, Mexico
Mexico, MEX, Mexico
Av. Cuauhtémoc 330, Doctores, MEX 06720, Mexico
Siglo Xxi, GUA, Mexico
Doctores, DIF, Mexico

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Effectiveness of the Treatment With Dapagliflozin and Metformin Compared to Metformin Monotherapy for Weight Loss on Diabetic and Prediabetic Patients With Obesity Class III
Effectiveness of the Treatment With Dapagliflozin and Metformin Compared to Metformin Monotherapy for Weight Loss on Diabetic and Prediabetic Patients With Obesity Class III
Enrollment Status: Completed
Publish Date: October 15, 2025
Intervention Type: Drug
Study Drugs: Dapagliflozin, Metformin
Study Phase: Phase 2/Phase 3

89 Total Publications

Correlation Between Glycemic Biomarkers and Continuous Glucose Monitoring Metrics in Chronic Kidney Disease: A Systematic Review and Correlation Meta-Analysis.
Correlation Between Glycemic Biomarkers and Continuous Glucose Monitoring Metrics in Chronic Kidney Disease: A Systematic Review and Correlation Meta-Analysis.
Journal: Journal of clinical medicine
Published: June 12, 2026

Frequently Asked Questions about Aldo Hermosillo-Ferreira

Is Aldo Hermosillo-Ferreira a top-rated expert for Type 1 Diabetes (T1D)?

MediFind is an objective health platform that identifies experts based on real-world data. Aldo Hermosillo-Ferreira is classified as an Advanced expert for Type 1 Diabetes (T1D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Aldo Hermosillo-Ferreira participate in research or clinical trials?

Yes. Aldo Hermosillo-Ferreira has published 89 articles and abstracts on conditions like Type 1 Diabetes (T1D). You can view a list of Aldo Hermosillo-Ferreira's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hermosillo-Ferreira's expertise for a condition
ConditionClose
      View All 34 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile